MARICEL LEPPALA: Open Payments
NPI 1255038451 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 28 payments from 8 companies in 2025. Trend: 2023 $86 · 2024 $98 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $299 |
| Intra-Sana Laboratories | 13 | $285 |
| AstraZeneca Pharmaceuticals LP | 3 | $139 |
| Daiichi Sankyo Inc. | 2 | $51 |
| PFIZER INC. | 2 | $36 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $24 |
| Amgen Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
Products named: RELTONE 200 MG, AIRSUPRA, Ozempic, INJECTAFER, Rybelsus, NURTEC ODT, OTEZLA, Cologuard Collection Kit.
Industry payments across NV — which companies pay providers there.
